NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
Back to search
Official data from USPTO
ENVISIONONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
11/12/2025
Trademark type
Word
Nice classes
42
Filing date
03/30/2024
Registration date
11/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/11/2025
Last transaction
11/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-09-00
First use in commerce
2024-09-00
Drawing code
4
Owner type
03
Owner location
Fairfield, CT
Examiner
GREEN,ASHLEY ELIZABETH
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Envision Pharma Inc.
Representatives
Zachary A. Aria Blank Rome LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Web site hosting services for the life sciencepharmaceutical and bio-pharmaceutical industriesacademic research organisations; Software as a service (SAAS) serviceshosting software for use by others for improving the efficiency in which companies bring products to market in the life sciencepharmaceutical and bio-pharmaceutical industriesacademic research organisations; Rental of software for improving the efficiency in which companies bring products to market in the life sciencepharmaceutical and bio-pharmaceutical industriesacademic research organisations; Platform as a service (PAAS) featuring computer software platforms for improving the efficiency in which companies bring products to market in the life sciencepharmaceutical and bio-pharmaceutical industriesacademic research organisations; Designdevelopment and implementation of software and software platforms for the life sciencepharmaceutical and bio-pharmaceutical industries and academic research organisations; Software development for others in the life sciencepharmaceutical and bio-pharmaceutical industriesacademic research organisations in the field of software configuration management; Providing a web hosting platform for the life sciencepharmaceutical and biopharmaceutical industries and academic research organisations; Installationmaintenancerepair and updating of computer software and computer software platforms for the life sciencepharmaceutical and bio-pharmaceutical industries and academic research organisations; Designdevelopment and implementation of software for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Software as a service (SAAS) serviceshosting software for global use by others for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Software development for others in the field of software configuration management for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Designdevelopment and implementation of software platforms that incorporate integrated and configurable software modules for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Platform as a service (PAAS) featuring computer software platforms incorporating integrated and configurable software modules for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Software development for others in the field of software platform configuration management for disclosing and disseminating scientific and medical data and informationmanaging evidence and tracking of scientific activity and grant requests; Technical support servicestechnical advice related to the repair of computer software; Technical support servicestechnical advice related to the maintenance of computer software; Consultancy services relating to software as a service (SAAS) services and the selection of software applications; Advisoryconsultancy and information services relating to all the aforesaid services
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/22/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/22/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/22/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/19/2025
IUAF
USE AMENDMENT FILED
04/28/2025
EISU
TEAS STATEMENT OF USE RECEIVED
04/28/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2025
PUBO
PUBLISHED FOR OPPOSITION
01/14/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/20/2024
GNRT
NON-FINAL ACTION E-MAILED
11/20/2024
CNRT
NON-FINAL ACTION WRITTEN
11/20/2024
DOCK
ASSIGNED TO EXAMINER
10/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/02/2024
NWAP
NEW APPLICATION ENTERED
03/30/2024
Continuous trademark protection
Get notified about every new filing that threatens ENVISIONONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.